Statistics for Autologous Bone Marrow Derived Mononuclear Cell Therapy for Spinal Cord Injury: A Phase I/II Clinical Safety and Primary Efficacy Data

Total visits

views
Autologous Bone Marrow Derived Mononuclear Cell Therapy for Spinal Cord Injury: A Phase I/II Clinical Safety and Primary Efficacy Data 0

Total visits per month

views
March 2026 0
April 2026 0
May 2026 0
June 2026 0
July 2026 0
August 2026 0
September 2026 0

File Visits

views
241.pdf 9